In vivo antitumour potential of camel’s milk against hepatocellular carcinoma in rats and its improvement of cisplatin renal side effects

References

• Arhoghro EM, Kpomah DE, Uwakwe AA. 2012. Curative potential of aqueous extract of lemon grass (Cymbopogon citratus) on cisplatin-induced hepatotoxicity in albino Wistar rats. J Phys Pharm Adv. 2:282–294.
   Google Scholar
• Arnesano F, Natile G. 2009. Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA. Coord Chem Rev. 253:2070–2081.
   Web of Science ®Google Scholar
• Athar M, Iqbal M. 1998. Ferric nitrilotriacetate promotes N-diethylnitrosamine induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress. Carcinogenesis. 19:1133–1139.
   PubMed Web of Science ®Google Scholar
• Behne T, Copur MS. 2012. Biomarkers for hepatocellular carcinoma. Int J Hepatol. 2012:859076. doi:10.1155/2012/859076
   PubMedGoogle Scholar
• Boorman GA, Eustis SL, Elwell MR, Montgomery CA, Mackenzie WF. 1990. Pathology of the Fisher rat. UK: Academic Press.
   Google Scholar
• Chakraborty T, Chatterjee A, Rana A, Rana B, Palanisamy A, Madhappan R, Chatterjee M. 2007. Suppression of early stages of neoplastic transformation in a two-stage chemical hepatocarcinogenesis model: supplementation of vanadium, a dietary micronutrient, limits cell proliferation and inhibits the formations of 8-hydroxy-2′-deoxyguanosines and DNA strand-breaks in the liver of Sprague-Dawley rats. Nutr Cancer. 59:228–247.
   PubMed Web of Science ®Google Scholar
• Cummings BS, Schnellmann RG. 2002. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther. 302:8–17.
   PubMed Web of Science ®Google Scholar
• Darwish HA, Abd Raboh NR, Mahdy A. 2012. Camel's milk alleviates alcohol-induced liver injury in rats. Food Chem Toxicol. 50:1377–1383.
   PubMed Web of Science ®Google Scholar
• Dickey DT, Muldoon LL, Doolittle ND, Peterson DR, Kraemer DF, Neuwelt EA. 2008. Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models. Cancer Chemother Pharmacol. 62:235–241.
   PubMed Web of Science ®Google Scholar
• El Miniawy HF, Ahmed KA, Tony MA, Mansour SA, Khattab MMS. 2014. Camel milk inhibits murine hepatic carcinogenesis initiated by diethylnitrosamine and promoted by phenobarbitone. Int J Vet Sci Med. 2:136–141.
   Google Scholar
• Farber E. 1984. The multistep nature of cancer development. Cancer Res. 44:4217–4223.
   PubMed Web of Science ®Google Scholar
• FitzGerald RJ, Meisel H. 2000. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr. 84:33–37.
   PubMed Web of Science ®Google Scholar
• Francescato HD, Costa RS, Rodrigues Camargo SM, Zanetti MA, Lavrador MA, Bianchi MD. 2001. Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats. Pharmacol Res. 43:77–82.
   PubMed Web of Science ®Google Scholar
• Gao J, Xie L, Yang W, Zhang W, Gao S, Wang J, Xiang Y. 2012. Risk factors of hepatocellular carcinoma – current status and perspectives. Asian Pacific J Cancer Prev. 13:743–752.
   PubMedGoogle Scholar
• Giaccone G. 2000. Clinical perspectives on platinum resistance. Drugs. 59:9–17.
   PubMed Web of Science ®Google Scholar
• González VM, Fuertes MA, Alonso C, Pérez JM. 2001. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol. 59:657–663.
   PubMed Web of Science ®Google Scholar
• Gorban AM, Izzeldin OM. 2001. Fatty acids and lipids of camel milk and colostrum. Int J Food Sci Nutr. 52:283–287.
   PubMed Web of Science ®Google Scholar
• Guo WJ, Zhou GD, Wu HJ, Liu YQ, Wu RG, Zhang WD. 2000. Ultrastructural localization of glutathione S-transferase-pi in human colorectal cancer cells. World J Gastroenterol. 6:454–455.
   PubMed Web of Science ®Google Scholar
• Gushiken FC. 2000. Peliosis hepatis after treatment with 2-chloro-3'-deoxyadenosine. South Med J. 93:625–626.
   PubMed Web of Science ®Google Scholar
• Hanigan MH, Devarajan P. 2003. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 1:47–61.
   PubMedGoogle Scholar
• Ito N, Tamano S, Shirai T. 2003. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals. Cancer Sci. 94:3–8.
   PubMed Web of Science ®Google Scholar
• Khan SM. 2006. Protective effect of black tea extract on the levels of lipid peroxidation and antioxidant enzymes in liver of mice with pesticide-induced liver injury. Cell Biochem Funct. 24:327–332.
   PubMed Web of Science ®Google Scholar
• Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Jr 2008. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 47:1363–1370.
   PubMed Web of Science ®Google Scholar
• Klaunig JE, Kamedulis LM. 2004. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 44:239–267.
   PubMed Web of Science ®Google Scholar
• Kohonen H, Pihlanto A. 2001. Food-derived bioactive peptides-opportunities for designing future foods. Curr Pharm Des. 9:1297–1308.
   Web of Science ®Google Scholar
• Kohonen H, Pihlanto A. 2003. Milk protein-derived bioactive peptides-novel opportunities for health promotion. IDF Bull. 363:17–26.
   Google Scholar
• Korashy HM, El Gendy MA, Alhaider AA, El- Kadi AO. 2012a. Camel milk modulates the expression of aryl hydrocarbon receptor-regulated genes, Cyp1a1, Nqo1, and Gst1a2, in murine hepatoma Hepa 1c1c7 cells. J Biomed Biotechnol. 2012:782642. doi:10.1155/2012/782642
   PubMedGoogle Scholar
• Korashy HM, Maayah ZH, Abd-Allah AR, El-Kadi AOS, Alhaider AA. 2012b. Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism. J Biomed Biotechnol. 2012:593195. doi:10.1155/2012/593195
   PubMedGoogle Scholar
• Langerak AD, Dreisbach LP. 2001. Chemotherapy regimens and cancer care. Georgetown, TX: Landes Bioscience.
   Google Scholar
• Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 47:469–474.
   PubMedGoogle Scholar
• Pradeep K, Mohan CVR, Gobianand K, Karthikeyan S. 2007. Silymarin modulates the oxidant-antioxidant imbalance during diethylnitrosamine-induced oxidative stress in rats. Euro J Pharmacol. 560:110–116.
   PubMed Web of Science ®Google Scholar
• Qin GZ, Ning YY, Su JJ, Shinozuka H, Lotlikar PD. 1998. Enhancement of aflatoxin B1-induced enzyme altered hepatic foci in rats by treatment with carbon tetrachloride. Exp Mol Med. 30:186–191.
   PubMed Web of Science ®Google Scholar
• Ramya B, Anjaneyulu Y, Gopala Reddy A, Madhuri D, Lakshman M, Shivakumar P. 2013. Protective role of turmeric on histological, ultrastructural and sero-biochemical changes in cisplatin-induced nephrotoxicity in female rats. Vet World. 6:865–869.
   Google Scholar
• Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. 1994. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids. 59:383–388.
   PubMed Web of Science ®Google Scholar
• Saad SY, Al-Rikabi AC. 2002. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy. 48:42–48.
   PubMed Web of Science ®Google Scholar
• Saltanat H, Li H, Xu Y, Wang J, Liu F, Geng XH. 2009. The influences of camel milk on the immune response of chronic hepatitis B patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 25:431–433.
   PubMedGoogle Scholar
• Salwa MQ, Lina AFK. 2010. Antigenotoxic and anticytotoxic effect of camel milk in mice treated with cisplatin. Saudi J Biol Sci. 17:159–166.
   PubMedGoogle Scholar
• Sharmanov TS, Zhangabylov AK, Zhaksylykova RD. 1982. Mechanism of the therapeutic action of whole mare’s and camel’s milk in chronic hepatitis. Vopr Pitan. 1:17–23.
   Google Scholar
• Sherman M. 2005. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 25:143–154.
   PubMed Web of Science ®Google Scholar
• Stewart HL, William G, keysser CH, Lombard LS, Montali RJ. 1980. Histologic typing of liver tumors in the rat. J Natl Cancer Inst. 64:179–206.
   Google Scholar
• Stroebel P, Mayer F, Zerban H, Bannasch P. 1995. Spongiotic pericytoma: a benign neoplasm deriving from the perisinusoidal (Ito) cells in rat liver. Am J Pathol. 146:903–913.
   PubMed Web of Science ®Google Scholar
• Suvarna SK, Layton C, Bancroft JD. 2012. Bancroft’s theory and practice of histological techniques. 7th ed. New York: Churchill Livingstone.
   Google Scholar
• Tatematsu M, Nagamine Y, Farber E. 1983. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res. 43:5049–5058.
   PubMed Web of Science ®Google Scholar
• Ueda N, Kaushal GP, Shah SV. 2000. Apoptotic mechanisms in acute renal failure. Am J Med. 108:403–415.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 160:1–40.
   PubMed Web of Science ®Google Scholar
• Van Gijssel HE, Maassen CB, Mulder GJ, Meerman JH. 1997. p53 protein expression by hepatocarcinogens in the rat liver and its potential role in Mito inhibition of normal hepatocytes as a mechanism of hepatic tumor promotion. Carcinogenesis. 18:1027–1033.
   PubMed Web of Science ®Google Scholar